Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole Extension Study in Schizophrenia
NCT01810783Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jul 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of brexpiprazole orally disintegrating tablet in schizophrenia, sponsored by Lundbeck. Started Jul 2013; status: completed.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01810783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810783.